JNJ-67856633
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for JNJ-67856633, covering 2025-06-22 to 2025-08-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia [Phase 1]